Skip to content

Can Hypermobility of First Ray Affect Surgical Treatment of Hallux Valgus

Can Hypermobility of First Ray Affect Surgical Treatment of Hallux Valgus: Randomized Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05051709
Enrollment
15
Registered
2021-09-21
Start date
2021-09-15
Completion date
2023-09-15
Last updated
2021-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Keywords

Hallux valgus, First ray hypermobility, Fusion, Corrective osteotomy, Functional outcome

Brief summary

Hallux valgus can be associated with hypermobility of 1st ray. Surgical decision for hallux valgus can be affected by hyper mobility of 1st ray so our clinical trial involved patients with bilateral hallux valgus were planned to underwent fusion of 1st ray and soft tissue correction plus bonionectomy for one foot and for other foot surgical treatment involves corrective osteotomy and soft tissue procedure plus bonionectomy without fusion of 1st tarsometatarsal joint.

Interventions

First metatarsal distal corrective osteotomy

PROCEDUREFusion of First ray

Fusion of first ray with soft tissue procedure

Sponsors

Hawler Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Hallux Valgus with 1st ray hypermobility

Exclusion criteria

1. Generalized Ligament laxity 2. Previous foot and ankle surgery 3. Diabetes Mellitus

Design outcomes

Primary

MeasureTime frameDescription
American foot and ankle scoreThis score was assessed one year after surgeryAmerican foot and ankle score involved 9 section
Foot and Ankle Disability IndexThis score was assessed one year after surgeryFoot and Ankle Disability Index involved 26 sections

Countries

Iraq

Contacts

Primary ContactSherwan Hamawndi, Ass. prof.
sherwan.hamawandi@hmu.edu.krd009644464321

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026